Cooperate to develop products with patented innovative structure to solve the pain points in clinical operation
With the improvement of living standards, the incidence of coronary heart disease is increasing year by year, which has become one of the major diseases endangering human life and health, and has caused great economic burden to patients.
There are two types of angiographic guidewire: Coil guidewire with spring wires covered on the outer layer and Hydrophilic coating guidewire with hydrophilic coating covered on the outer layer. The advantages of Coil guidewire are higher hardness, better support and safer operation, but when the blood vessel is tortuous, its traversing ability is not very well. Because of the above reasons, many hospitals now use hydrophilic coating guidewire for surgery. The hydrophilic coating guidewire has very good traversability, but its controllability is poor, and it is easy to cause complications during operation. According to statistics, 5%~8% of the complications of transradial artery interventional diagnosis and treatment are directly or indirectly caused by hydrophilic coating guidewire, which increases the risk of operation and causes unnecessary pain for patients. Therefore, the project team hopes to develop one type of angiographic guidewire with excellent traversability and controllability.
In order to achieve the goal of the project, in 2012, we invited well-known experts from the third-class hospitals in China to communicate with our technicians, and confirmed the direction of product development.